Laurion Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-700,000
| Closed | -$20.2M | – | 603 |
|
|
2023
Q4 | $20.2M | Sell |
700,000
-300,000
| -30% | -$9.07M | 0.17% | 116 |
|
|
2023
Q3 | $33.2M | Hold |
1,000,000
| – | – | 0.2% | 100 |
|
|
2023
Q2 | $36.7M | Buy |
1,000,000
+500,000
| +100% | +$19.5M | 0.21% | 106 |
|
|
2023
Q1 | $20.4M | Buy |
+500,000
| New | +$21.6M | 0.14% | 141 |
|
|
2022
Q3 | – | Sell |
-105,000
| Closed | -$5.5M | – | 585 |
|
|
2022
Q2 | $5.5M | Buy |
+105,000
| New | +$5.35M | 0.09% | 149 |
|
|
2020
Q3 | – | Sell |
-293,961
| Closed | -$9.12M | – | 1077 |
|
|
2020
Q2 | $9.12M | Buy |
+293,961
| New | +$9.99M | 0.1% | 184 |
|
|
2019
Q4 | – | Sell |
-4,848
| Closed | -$166K | – | 1149 |
|
|
2019
Q3 | $166K | Buy |
+4,848
| New | +$176K | ﹤0.01% | 935 |
|
|
2019
Q1 | – | Sell |
-97,917
| Closed | -$4.05M | – | 1198 |
|
|
2018
Q4 | $4.05M | Sell |
97,917
-190,457
| -66% | -$7.91M | 0.07% | 330 |
|
|
2018
Q3 | $12.1M | Buy |
288,374
+190,457
| +195% | +$7.33M | 0.12% | 198 |
|
|
2018
Q2 | $3.37M | Hold |
97,917
| – | – | 0.03% | 453 |
|
|
2018
Q1 | $3.3M | Sell |
97,917
-832,660
| -89% | -$28.6M | 0.03% | 477 |
|
|
2017
Q4 | $32M | Hold |
930,577
| – | – | 0.16% | 140 |
|
|
2017
Q3 | $31.5M | Hold |
930,577
| – | – | 0.14% | 129 |
|
|
2017
Q2 | $29.7M | Sell |
930,577
-371,113
| -29% | -$11.7M | 0.16% | 122 |
|
|
2017
Q1 | $42.3M | Buy |
1,301,690
+428,029
| +49% | +$13.5M | 0.32% | 73 |
|
|
2016
Q4 | $26.9M | Buy |
873,661
+188,561
| +28% | +$5.76M | 0.26% | 98 |
|
|
2016
Q3 | $22M | Hold |
685,100
| – | – | 0.21% | 107 |
|
|
2016
Q2 | $22.9M | Buy |
+685,100
| New | +$21.9M | 0.36% | 62 |
|
|
2016
Q1 | – | Sell |
-1,475,600
| Closed | -$45.2M | – | 1022 |
|
|
2015
Q4 | $45.2M | Buy |
1,475,600
+140,287
| +11% | +$4.41M | 0.42% | 51 |
|
|
2015
Q3 | $39.8M | Sell |
1,335,313
-1,563,187
| -54% | -$50.1M | 0.46% | 53 |
|
|
2015
Q2 | $92.2M | Buy |
2,898,500
+2,740,400
| +1,733% | +$89.3M | 0.85% | 19 |
|
|
2015
Q1 | $5.22M | Hold |
158,100
| – | – | 0.1% | 162 |
|
|
2014
Q4 | $4.67M | Hold |
158,100
| – | – | 0.11% | 92 |
|
|
2014
Q3 | $4.44M | Sell |
158,100
-527,000
| -77% | -$14.8M | 0.09% | 131 |
|
|
2014
Q2 | $19.3M | Buy |
+685,100
| New | +$19.5M | 0.41% | 78 |
|
|
2014
Q1 | – | Sell |
-142,395
| Closed | -$4.14M | – | 298 |
|
|
2013
Q4 | $4.14M | Buy |
+142,395
| New | +$4.14M | 0.14% | 79 |
|
Other funds holding PFE
Laurion Capital Management's PFE Position: Q2 2025 in Review
Laurion Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 196,886 shares — an estimated $4.99M sold.
Laurion Capital Management first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $70.4M in Q4 2023. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Laurion Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Laurion Capital Management sold 196,886 Pfizer shares in Q2 2025, an estimated $4.99M.
- Laurion Capital Management first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Laurion Capital Management's Pfizer position peaked at $70.4M in Q4 2023.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.